Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | GFER | P55789 | 1/20 | 0.35 |
| ▸ | CES2 | O00748 | 2/20 | 0.35 |
| ▸ | CES1 | P23141 | 2/20 | 0.35 |
| ▸ | DAO | P14920 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | AKT1 | P31749 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6058838 | 1.00 | ALDH1A1 (0.50) | ALDH1A1SMN1; SMN2CYP1A2NPSR1GAA | |
| SCHEMBL12858417 | 1.00 | ALDH1A1 (0.50) | ALDH1A1SMN1; SMN2CYP1A2NPSR1GAA | |
| SCHEMBL2652012 | 0.82 | ALDH1A1 (0.47) | ALDH1A1SMN1; SMN2CYP1A2NPSR1GAA | |
| SCHEMBL2652009 | 0.82 | ALDH1A1 (0.47) | ALDH1A1SMN1; SMN2CYP1A2NPSR1GAA | |
| SCHEMBL2652015 | 0.82 | CYP2C19 (0.41) | ALDH1A1SMN1; SMN2NPSR1GAACYP2C19 | |
| SCHEMBL29155533 | 0.79 | KDM1A (0.42) | ALDH1A1SMN1; SMN2CYP1A2NPSR1GAA | |
| SCHEMBL8388187 | 0.77 | CES2 (0.39) | ALDH1A1SMN1; SMN2CYP1A2CES2CES1 | |
| SCHEMBL8383853 | 0.77 | CES2 (0.39) | ALDH1A1GAACES2CES1TSHR | |
| SCHEMBL8388561 | 0.77 | ALDH1A1 (0.40) | ALDH1A1SMN1; SMN2NPSR1GAAHPGD | |
| SCHEMBL8388563 | 0.77 | ALDH1A1 (0.40) | ALDH1A1SMN1; SMN2NPSR1GAAHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119320486-A | Multiple dynamic room temperature self-repairing polyurethane elastomer and preparation method thereof | 北京理工大学 | 2025-01-17 | — | — | CN | claimed |
| CN-119320486-A | Multiple dynamic room temperature self-repairing polyurethane elastomer and preparation method thereof | 北京理工大学 | 2025-01-17 | — | — | CN | disclosed |
| CN-118804960-A | Cerium oxide based slurry composition for selective and non-selective CMP of silicon oxides, silicon nitrides and polysilicon | CMC材料有限责任公司 | 2024-10-18 | — | — | CN | disclosed |
| CN-118255701-A | Disulfide-based dihydroxyoxime acid compound as well as preparation method and application thereof | 中南大学 | 2024-06-28 | — | — | CN | disclosed |
| CN-117062626-A | Methods and compositions for treating sleep apnea | 爱普宁公司(特拉华) | 2023-11-14 | — | — | CN | disclosed |
| US-10710905-B2 | Water treatment method, and associated module and facility | SUEZ GROUPE (FR) | 2020-07-14 | — | — | US | disclosed |
| US-20180370818-A1 | WATER TREATMENT METHOD, AND ASSOCIATED MODULE AND FACILITY | SUEZ INTERNATIONAL (FR) | 2018-12-27 | — | — | US | disclosed |
| EP-3390283-A1 | WATER TREATMENT METHOD, AND ASSOCIATED MODULE AND FACILITY | SUEZ Groupe (FR) | 2018-10-24 | — | — | EP | disclosed |
| EP-1716188-A1 | CLATHROCHELATES AS OLEFIN POLYMERIZATION CATALYST COMPONENTS | Equistar Chemicals, LP (US) | 2006-11-02 | — | — | EP | disclosed |
| US-7026415-B2 | Clathrochelates as olefin polymerization catalyst components | EQUISTAR CHEMICALS, LP (US) | 2006-04-11 | — | — | US | disclosed |
| WO-2005082955-A1 | CLATHROCHELATES AS OLEFIN POLYMERIZATION CATALYST COMPONENTS | EQUISTAR CHEMICALS, LP (US) | 2005-09-09 | — | — | WO | disclosed |
| US-20050182211-A1 | Clathrochelates as olefin polymerization catalyst components | EQUISTAR CHEMICALS, LP | 2005-08-18 | — | — | US | disclosed |
| EP-0942911-B1 | BENZOPYRANOPYRROLE AND BENZOPYRANOPYRIDINE ALPHA-1 ADRENERGIC COMPOUNDS | ABBOTT LAB (US) | 2001-10-17 | — | — | EP | disclosed |
| US-6046207-A | FOR INHIBITING ALPHA-1 ADRENORECEPTORS AND TREATING BENIGN PROSTATIC HYPERPLASIA, ALSO CALLED BENIGN PROSTATIC HYPERTROPHY, OR OTHER UROLOGICAL OR GYNECOLOGICAL DISEASES SUCH AS BLADDER OUTLET OBSTRUCTION, NEUROGENIC BLADDER | ABBOTT LABORATORIES | 2000-04-04 | — | — | US | disclosed |
| EP-0942911-A1 | BENZOPYRANOPYRROLE AND BENZOPYRANOPYRIDINE ALPHA-1 ADRENERGIC COMPOUNDS | Abbott Laboratories (US) | 1999-09-22 | — | — | EP | disclosed |
| US-5869683-A | Processes for producing 1-substituted-2-cyanoimidazole compounds | ISHIHARA SANGYO KAISHA, LTD. (JP) | 1999-02-09 | — | — | US | disclosed |
| WO-1998024791-A1 | BENZOPYRANOPYRROLE AND BENZOPYRANOPYRIDINE ALPHA-1 ADRENERGIC COMPOUNDS | ABBOTT LABORATORIES (US) | 1998-06-11 | — | — | WO | disclosed |
| EP-0705823-A1 | Process for producing 1-substituted-2-cyanoimidazole compounds | ISHIHARA SANGYO KAISHA LTD. (JP) | 1996-04-10 | — | — | EP | disclosed |
| US-4052194-A | GLYOXIME, DICHLOROGLYOXIME OR SALTS | WILCOX MERRILL | 1977-10-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050182211-A1 | Clathrochelates as olefin polymerization catalyst components | METTL14, CLTC, MTCL3 | ALDH1A1 4576/4885SMN1; SMN2 4693/4885CYP1A2 3809/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.